BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16681897)

  • 1. [To enhance the research of antibiotic resistance and infection caused by drug-resistance bacteria].
    Wang F
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):579-80. PubMed ID: 16681897
    [No Abstract]   [Full Text] [Related]  

  • 2. Selection of antibiotic-resistant pathogens in the community.
    Yagupsky P
    Pediatr Infect Dis J; 2006 Oct; 25(10):974-6. PubMed ID: 17006309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop.
    Tomasz A
    N Engl J Med; 1994 Apr; 330(17):1247-51. PubMed ID: 8139650
    [No Abstract]   [Full Text] [Related]  

  • 4. [Research and practice of antibiotic strategies for controlling and avoiding bacterial resistance].
    He LX
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):2-3. PubMed ID: 16606525
    [No Abstract]   [Full Text] [Related]  

  • 5. Antibiotic resistance in the community.
    Lim VK
    Med J Malaysia; 2003 Jun; 58(2):156-8. PubMed ID: 14569734
    [No Abstract]   [Full Text] [Related]  

  • 6. [Natural history of antibiotic resistance of community bacteria].
    Baquero F
    Rev Pneumol Clin; 2000 Oct; Suppl 1():1S3-6. PubMed ID: 11103979
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibiotic and antifungal resistance in antibiotic "free" environment?
    Krcmery V; Kalavsky E
    Neuro Endocrinol Lett; 2007 Nov; 28 Suppl 3():33-4. PubMed ID: 18030277
    [No Abstract]   [Full Text] [Related]  

  • 8. First detection of plasmid-mediated quinolone resistance in the community setting and in hospitalized patients in Switzerland.
    Liassine N; Zulueta-Rodriguez P; Corbel C; Lascols C; Soussy CJ; Cambau E
    J Antimicrob Chemother; 2008 Nov; 62(5):1151-2. PubMed ID: 18669519
    [No Abstract]   [Full Text] [Related]  

  • 9. Approaches to reduce antibiotic resistance in the community.
    Cohen R
    Pediatr Infect Dis J; 2006 Oct; 25(10):977-80. PubMed ID: 17006310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Community-acquired bacterial respiratory tract infections.
    Brunton S; Carmichael B; Fitzgerald M; Liu H; Varon J; Weiland D
    J Fam Pract; 2005 Mar; 54(3):255-62. PubMed ID: 15755379
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pay attention to the antibiotic resistance of the pathogenic bacteria causing community-acquire respiratory infections in childhood].
    Yang YH
    Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):584-6. PubMed ID: 16681899
    [No Abstract]   [Full Text] [Related]  

  • 12. Reducing antimicrobial resistance in the community by restricting prescribing: can it be done?
    Enne VI
    J Antimicrob Chemother; 2010 Feb; 65(2):179-82. PubMed ID: 20008449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic resistance: current data from around the world and Tunisia].
    Ben Redjeb S
    Tunis Med; 1999 Oct; 77(10):472-7. PubMed ID: 10670277
    [No Abstract]   [Full Text] [Related]  

  • 14. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.
    Gyssens IC
    Clin Microbiol Infect; 2008 Oct; 14(10):889-91. PubMed ID: 18828849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of community and hospital acquired bacteria.
    Danchaivijitr S; Dhiraputra C; Rongrungruang Y; Worajitr M; Jintanothaitavorn D
    J Med Assoc Thai; 2005 Dec; 88 Suppl 10():S14-25. PubMed ID: 16850635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of complicated community-acquired infections with ertapenem, the first Group 1 carbapenem. Introduction.
    Goldstein EJ
    J Antimicrob Chemother; 2004 Jun; 53 Suppl 2():ii5-6. PubMed ID: 15228047
    [No Abstract]   [Full Text] [Related]  

  • 17. Emerging antibiotic resistance among community-acquired and nosocomial bacterial pathogens.
    Capriotti T
    Medsurg Nurs; 1997 Oct; 6(5):296-8, 303. PubMed ID: 9384157
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis.
    Cheong HS; Kang CI; Lee JA; Moon SY; Joung MK; Chung DR; Koh KC; Lee NY; Song JH; Peck KR
    Clin Infect Dis; 2009 May; 48(9):1230-6. PubMed ID: 19302016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fighting bacterial resistance at the root: need for adapted EMEA guidelines.
    Andremont A; Bonten M; Kluytmans J; Carmeli Y; Cars O; Harbarth S
    Lancet Infect Dis; 2011 Jan; 11(1):6-8. PubMed ID: 21183140
    [No Abstract]   [Full Text] [Related]  

  • 20. The issue of antimicrobial resistance in human medicine.
    Beović B
    Int J Food Microbiol; 2006 Dec; 112(3):280-7. PubMed ID: 16815582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.